Karnataka issues alert over cough syrups; health minister urges parental caution

Published on: Oct 06, 2025 05:15 pm IST

Karnataka has issued a statewide alert due to child deaths linked to contaminated cough syrups in other states.

Karnataka has issued a statewide alert after reports of child deaths linked to contaminated cough syrups in Madhya Pradesh and Rajasthan, Health Minister Dinesh Gundu Rao said on Monday.

Chief Minister Siddaramaiah has directed the health department to investigate the matter.
Chief Minister Siddaramaiah has directed the health department to investigate the matter.

Chief Minister Siddaramaiah has directed the health department to investigate the matter and ensure no such products enter Karnataka, news agency PTI reported.

(Also Read: Karnataka gang kills disabled man, stages motorbike crash to claim 5.25 crore insurance)

Gundu Rao clarified that the "substandard" syrups linked to the deaths elsewhere have not been supplied or sold in Karnataka so far. “We have already instructed officials to check whether any of these products were sold in the state. As per our information, none have come to Karnataka,” he said according to the report.

As a precautionary step, samples of all cough syrup brands are being collected and tested by the state’s Drug Control Department. “We have taken preventive measures and are on high alert. Karnataka is among the leading states in conducting drug quality tests,” the minister added.

Rao has also asked officials to issue guidelines on the safe use of cough syrups, especially for children under the age of five.

He urged parents to exercise caution and avoid unnecessary use of cough syrups for infants and toddlers. The minister attributed the child deaths in other states to the “negligence” of certain drug manufacturers.

“The Centre must enact stricter laws against drug adulteration and improve coordination between states,” Rao said. He added that he had previously written to the Union Health Ministry seeking stronger monitoring and the creation of a national information-sharing portal for reporting cases of drug contamination.

According to a circular dated October 5, the Food Safety and Drugs Administration (FSDA) highlighted recent incidents where child deaths in Madhya Pradesh were linked to Coldrif Syrup (Batch No. SR-13), manufactured by a Tamil Nadu-based firm. The Tamil Nadu Drugs Control Department has since banned the sale and use of that batch in the state.

Similarly, a few child deaths in Rajasthan were reported after the consumption of Dextromethorphan Hydrobromide Syrup IP, produced by Kaysons Pharma, Jaipur, the circular stated.

(Also Read: No network, no survey: Karnataka villagers boycott Caste Census over poor connectivity)

Catch every big hit, every wicket with Crickit, a one stop destination for Live Scores, Match Stats, Infographics & much more. Explore now!

Stay updated Bengaluru Weather Live and with all the Breaking News and Latest News from Bengaluru. Click here for comprehensive coverage of top cities including Delhi, Mumbai, Hyderabad, and more across India . Stay informed on the latest happenings in World News.
Catch every big hit, every wicket with Crickit, a one stop destination for Live Scores, Match Stats, Infographics & much more. Explore now!

Stay updated Bengaluru Weather Live and with all the Breaking News and Latest News from Bengaluru. Click here for comprehensive coverage of top cities including Delhi, Mumbai, Hyderabad, and more across India . Stay informed on the latest happenings in World News.
SHARE THIS ARTICLE ON
SHARE
close
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
Get App
crown-icon
Subscribe Now!
AI Summary AI Summary

Karnataka has issued an alert following child deaths linked to contaminated cough syrups in Madhya Pradesh and Rajasthan. Health Minister Dinesh Gundu Rao confirmed no such products have been sold in Karnataka, but officials are investigating and testing all cough syrup brands. Precautionary measures include guidelines for safe usage, especially for children under five, amid calls for stricter drug regulation.